High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Children'S Hospital
San Francisco, California, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2016
- Primary completion
- 1 Dec 2021
- Completion
- 30 Sept 2024
- Last update posted
- 22 Oct 2024
- Registered enrollment
- 170
- Registry id
- NCT02860039
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.